For investors who still feel sick from the ups and downs of a volatile market, Johnson & Johnson may bring some relief. "If you are looking for the ultimate in safety," says Perkins of Johnson Asset Management, "J&J certainly fits that bill."
Perkins points to J&J's AAA-rated balance sheet, strong growth opportunities, and inexpensive stock price, off its high of $70 in the fourth quarter of last year. J&J is trading at only 14 times its estimated 2008 earnings and has a solid 2.7% dividend yield. "It's not only a safe place to hide," says Perkins, "but offers investors a high-quality long-term-return opportunity."